Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (atsiveria naujas langas)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Šaltinis‎: Cancer 2013;119(21):3784-7.

Kodas‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (atsiveria naujas langas)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (atsiveria naujas langas)

Chakrabarti S, Varma S, Singh S, Kumari S

Šaltinis‎: Eur J Haematol 1998;60(5):313-4.

Kodas‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (atsiveria naujas langas)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (atsiveria naujas langas)

Delaney M, Matthews DC, Gernsheimer TB

Šaltinis‎: Pediatr Blood Cancer 2017;64(12):e26641.

Kodas‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (atsiveria naujas langas)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (atsiveria naujas langas)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Šaltinis‎: J Urol 2010;184(3):1152-7.

Kodas‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (atsiveria naujas langas)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (atsiveria naujas langas)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Šaltinis‎: Leuk Lymphoma 1995;19(1-2):141-4.

Kodas‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (atsiveria naujas langas)

Pediatric off-label use of recombinant factor VIIa. (atsiveria naujas langas)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Šaltinis‎: Pediatrics 2009;123(3):1066-72.

Kodas‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (atsiveria naujas langas)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (atsiveria naujas langas)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Šaltinis‎: Indian J Pediatr 2011;78(8):961-8.

Kodas‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (atsiveria naujas langas)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (atsiveria naujas langas)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Šaltinis‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Kodas‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (atsiveria naujas langas)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (atsiveria naujas langas)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Šaltinis‎: Pediatr Blood Cancer 2016;63(10):1822-8.

Kodas‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (atsiveria naujas langas)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (atsiveria naujas langas)

Das P, Carcao M, Hitzler J

Šaltinis‎: Pediatr Blood Cancer 2006;47(2):206-9.

Kodas‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (atsiveria naujas langas)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (atsiveria naujas langas)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Šaltinis‎: Pediatr Blood Cancer 2008;50(5):1013-7.

Kodas‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (atsiveria naujas langas)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (atsiveria naujas langas)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Šaltinis‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

Kodas‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (atsiveria naujas langas)

Off-label use of recombinant factor VIIa in pediatric patients. (atsiveria naujas langas)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Šaltinis‎: Pediatrics 2012;129(6):e1533-40.

Kodas‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (atsiveria naujas langas)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (atsiveria naujas langas)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Šaltinis‎: Pediatr Blood Cancer 2013;60(7):1178-83.

Kodas‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (atsiveria naujas langas)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (atsiveria naujas langas)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Šaltinis‎: Med Oncol 2010;27(1):16-9.

Kodas‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (atsiveria naujas langas)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (atsiveria naujas langas)

Ucar C, Caliskan U

Šaltinis‎: Pediatr Hematol Oncol 2006;23(4):339-45.

Kodas‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (atsiveria naujas langas)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (atsiveria naujas langas)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Šaltinis‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Kodas‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (atsiveria naujas langas)

The use of DDAVP in children with bleeding disorders. (atsiveria naujas langas)

Ben-Ami T, Revel-Vilk S

Šaltinis‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

Kodas‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (atsiveria naujas langas)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (atsiveria naujas langas)

Kobrinsky NL, Tulloch H

Šaltinis‎: J Pediatr 1988;112(6):993-6.

Kodas‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (atsiveria naujas langas)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (atsiveria naujas langas)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Šaltinis‎: J Pediatr Surg 2013;48(3):689-94.

Kodas‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (atsiveria naujas langas)